Replimune (REPL) Total Current Liabilities (2018 - 2026)

Replimune (REPL) posted Total Current Liabilities of $58.2 million for Q1 2026, up 16.25% sequentially from $50.1 million in Q4 2025, and down 6.63% YoY from $62.4 million in Q1 2025.

Replimune (REPL) Total Current Liabilities (2018 - 2026) Analysis & Trends

Replimune has reported Total Current Liabilities for 9 years, with the latest figure at $58.2 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 6.63% year-over-year to $58.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.2 million (down 6.63% YoY) and the FY2026 annual result came in at $58.2 million, down 6.63% from the prior year.
  • Total Current Liabilities improved to $58.2 million in Q1 2026 per REPL's latest filing, from $50.1 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $62.4 million in Q1 2025 and troughed at $20.3 million in Q2 2022.
  • A 5-year average of $40.4 million and a median of $39.8 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2023 and 2026: Total Current Liabilities surged 69.23% in 2023, then slipped 6.63% in 2026.
  • Over 5 years, Total Current Liabilities stood at $26.5 million in 2022, then soared by 46.05% to $38.6 million in 2023, then climbed by 23.91% to $47.9 million in 2024, then increased by 4.59% to $50.1 million in 2025, then rose by 16.25% to $58.2 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $58.2 million, $50.1 million, and $52.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 Replimune 1.24 Bn 1.24 Bn - 58.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 58.23 Mn
Dec 31, 2025 50.09 Mn
Sep 30, 2025 52.90 Mn
Jun 30, 2025 59.56 Mn
Mar 31, 2025 62.36 Mn
Dec 31, 2024 47.89 Mn
Sep 30, 2024 43.79 Mn
Jun 30, 2024 35.68 Mn
Mar 31, 2024 40.44 Mn
Dec 31, 2023 38.65 Mn
Sep 30, 2023 39.83 Mn
Jun 30, 2023 32.24 Mn
Mar 31, 2023 33.83 Mn
Dec 31, 2022 26.46 Mn
Sep 30, 2022 23.54 Mn
Jun 30, 2022 20.31 Mn
Mar 31, 2022 20.76 Mn
Dec 31, 2021 18.29 Mn
Sep 30, 2021 16.64 Mn
Jun 30, 2021 15.05 Mn